Position in FATE
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$121,170
-$47,667 QoQ
Shares Held
100,975
-41.4% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 92.37435008665511.ToString("F0")%
Shared 0.ToString("F0")%
None 7.625649913344887.ToString("F0")%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Derivatives in FATE
reported options exposure · as of Sep 30, 2020CallValue
$679,490
CallShares
17,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. FATE ranks #211 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in FATE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $121,170 | 100,975 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $168,837 | 172,283 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $168,637 | 133,839 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $136,854 | 122,192 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $81,320 | 102,938 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $152,450 | 92,395 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $206,887 | 59,111 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $187,786 | 57,252 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $301,034 | 41,013 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $143,390 | 38,340 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $72,726 | 34,305 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,009,709 | 212,124 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,532,883 | 268,927 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $511,470 | 50,691 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,044,751 | 46,620 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,130,188 | 45,609 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,520,768 | 142,398 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $10,657,302 | 182,145 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $22,587,262 | 381,091 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $28,360,279 | 326,769 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $17,150,256 | 208,008 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $20,707,578 | 227,731 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $9,914,397 | 248,046 | Shares | Defined | 2020-11-05 | |
| 2020-09-30 | $679,490 | 17,000 | Call | Defined | 2020-11-05 | |
| 2020-06-30 | $11,795,776 | 343,800 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $9,409,286 | 423,651 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||